Analyst Upgrades

• Cree (CREE) and Rubicon Technology (RBCN) to buy from neutral at Merriman.
• Children's Place (PLCE) to outperform from market perform at BMO Capital.
• Lockheed Martin (LMT) to neutral from underperform at BofA/Merrill.
• Copano Energy (CPNO) to outperform from market perform at Morgan Keegan.
• Motorola Mobility (MMI) to neutral from reduce at Nomura.
• Parker-Hannifin (PH) to buy from hold at KeyBanc.
• Akamai (AKAM), ShoreTel (SHOR), AMB Property (AMB) and ProLogis (PLD) to buy from hold at Stifel Nicolaus.

Coca-Cola (KO) has more than $13 billion in cash.

The top five companies (according to market cap) are:

• Exxon Mobil (XOM): $398.3 billion
• Apple (AAPL): $309.0 billion
• Microsoft (MSFT): $237.5 billion
• General Electric (GE): $215.0 billion
• Berkshire Hathaway (BRK.A): $202.5 billion

This week got off to a good start considering that last Friday was a rough day in the market due to the geopolitics of the day. Egypt is not getting much better and the economy has come to a stop as no one is back at work yet. Still, things aren't getting worse. This offered some stability to the region. Brent Sea crude hit $100 per barrel today. Data from the PMI showed that inflation at the wholesale level continues to firm, while spending seems to outstrip income again.

Here were today's unofficial closing bell levels:

Dow Jones 11,891.93 +68.23 (0.58%)
S&P 500 1,286.12 +9.78 (0.77%)
Nasdaq 2,700.08 +13.19 (0.49%)

Top Analyst upgrades and downgrades

Analyst Upgrades

• SuperValu (SVU) to buy from hold at Hapoalim.
• Constellation Energy (CEG) to buy from hold at Citigroup.
• Doral Financial (DRL) to neutral from sell and ABB (ABB) to buy from neutral at Sterne Agee.

Analyst Downgrades

• American Eagle (AEO) to neutral from buy at SunTrust.
• Tenet Healthcare (THC) to market perform from outperform at Wells Fargo.

Analyst upgrades:

• CLSA upgraded Freeport McMoRan (FCX) to Buy from Sell and has a price target of $85 based on expectations for improved copper prices. The analyst believes China is mostly done with tightening measures and that downside in copper prices is limited.
• Jefferies upgraded Concur Tech (CNQR) to Buy from Hold due to improvements in corporate travel and structural growth drivers from international and SMB. The firm has a price target of $55 on the stock.
• Deutsche Bank upgraded ESCO Technologies (ESE) to Buy from Hold on expectations the company will announce a contract with SoCal Gas within two months. The firm upped its target for shares to $35 from $33.
• Wells Fargo (WFC) was raised to Outperform from Market Perform at FBR Capital.
• Human Genome (HGSI) was upgraded to Outperform from Neutral at Baird.
• Brown & Brown (BRO) was upgraded to Neutral from Underweight at JP Morgan.

Analyst downgrades:

• Canaccord downgraded Netflix (NFLX) to Hold from Buy following the Q2 report and has a $107 price target on the stock. The firm is growing more cautious on ARPU pricing pressure, higher churn rates and higher SAC.
• Deutsche Bank downgraded Airgas (ARG) to Hold from Buy following the company's Q1 results due to valuation. The firm has a $65 price target for shares. Note shares were also downgraded at Soleil this morning.
• Goldman downgraded Piper Jaffray (PJC) to Neutral from Buy and lowered its price target to $35 from $46. The firm said Piper's ROE remains below peers.
• AMB Property (AMB) was downgraded to Neutral from Buy at BofA/Merrill.
• Odyssey Healthcare (ODSY) was downgraded to Negative from Neutral at Susquehanna.
• Trina Solar (TSL) was downgraded to Outperform from Strong Buy at Raymond James.

Analyst initiations:

• BofA/Merrill started Cognizant Technology (CTSH) with a Neutral rating.
• Stifel Nicolaus initiated Brigham Exploration (BEXP) with a Buy rating and $24 target.
• ThinkEquity assumed Dick's Sporting (DKS) with a Buy rating.
• Petrohawk Energy (HK) was initiated with a Perform rating at Oppenheimer.
• E.ON AG (EONGY) was initiated with a Buy rating at RBS.
• Atlas Energy (ATLS) was initiated with an Outperform rating at BMO Capital.

Analyst upgrades:

• UBS upgraded Salesforce.com (CRM) to Buy from Neutral based on positive feedback on the Chatter product and increasing confidence the company can beat FY11 guidance. The firm raised its price target to $111 from $90.
• Leerink upgraded Vivus (VVUS) to Outperform from Market Perform. The firm believes Qnexa issues raised by the FDA are labeling and marketing issues, and not approval issues. The firm expects a positive panel vote for Qnexa.
• Goldman upgraded AK Steel (AKS) to Buy from Netural citing lower iron ore prices. The firm has a $17 price target on the stock.
• Kinder Morgan Energy (KMP) was upgraded to Equal Weight at Morgan Stanley.
• Shire (SHPGY) was upgraded to Outperform from Neutral at Credit Suisse.
• Canadian National (CNI) was upgraded to Outperform from Market Perform at Raymond James.

Analyst Upgrades

• FBR Capital upgraded Transocean (RIG) to outperform from market perform as it believes congressional hearings and reports indicate the company's blowout preventer at the Deepwater Horizon likely worked properly. The firm has an $87 price target for shares.
• Auriga upgraded First Solar (FSLR) to buy from hold as it believes the recent sell-off in shares as created an attractive entry point. Despite upgrading, the firm lowered its target for shares to $138 from $147.
• Soleil upgraded Priceline.com (PCLN) to buy from hold, citing a favorable risk-reward profile. Despite the upgrade, the firm lowered its target for shares to $230 from $250.
• Blackrock (BLK) was upgraded to conviction buy from buy at Goldman.
• Abbott (ABT) was upgraded to hold from sell at Citigroup.
• Exxon Mobil (XOM) was upgraded to outperform from sector perform at RBC Capital.

Analyst upgrades:

• Jefferies upgraded CME Group (CME) to Buy from Hold and has a $330 target on the stock. The firm believes increased regulatory concerns have created a buying opportunity and notes that CME Group's fundamentals are stable-to-improving.
• Susquehanna upgraded Priceline.com (PCLN) to Positive from Neutral and has a $230 target on the stock. The firm believes Priceline.com likely outperformed expectations in Q4.
• Citigroup upgraded AutoZone (AZO) to Buy from Hold citing an attractive valuation, favorable industry trends, and the potential for margin expansion. The firm raised its target price on shares to $188 from $176.
• Genzyme (GENZ) was raised to Sell from Conviction Sell at Goldman.
• Disney (DIS) was upgraded to Neutral from Underweight at JP Morgan.
• Exxon Mobil (XOM) was upgraded at Collins Stewart to Buy from Hold.

Analyst Upgrades

• Oppenheimer upgraded Hubbell (HUB.B) to outperform from perform to reflect the company's improving operations, margin expansion and valuation. The firm raised its target price on shares to $53 from $51.
• UBS upgraded Weingarten Realty (WRI) and Taubman Centers (TCO), Boston Properties (BXP), ProLogis (PLD) and AMB Property (AMB) to neutral from sell and SL Green Realty (SLG) to buy from neutral, citing the recent correction in the group.
• Benchmark Co. upgraded Time Warner (TWX) to buy from hold on expectations the company is positioned for steady, sustainable growth as advertising demand rebounds. The firm has a $35 price target on shares.
• Eastman Chemical (EMN) was upgraded to overweight from neutral at JPMorgan.
• Constellation Energy (CEG) was upgraded to overweight from equal weight at Barclays.
• Noble Corporation (NE) was upgraded to outperform from market perform at FBR Capital.

Analyst Upgrades

• Deutsche Bank upgraded Research in Motion (RIMM) to hold from sell to reflect the company's Q3 results and guidance. The firm raised its target price on shares to $75 from $60.
• Keefe Bruyette upgraded Northern Trust (NTRS) and State Street (STT) to outperform from market perform to reflect valuation and favorable longer-term secular trends. The firm keeps a $58 price target on Northern Trust and a $51 target on State Street.
• UBS upgraded Universal Health (UHS) to buy from neutral and raised its target to $38 from $31. The firm said hospital checks indicate bad debt has not increased vs. Q3 and that Universal Health should report an in-line to better-than-expected Q4.
• Take-Two Interactive (TTWO) was upgraded to hold from sell at Kaufman Bros.
• Whiting Petroleum (WLL) was raised to outperform from market perform at Wells Fargo.
• BP Plc (BP) was upgraded at Goldman to buy from neutral.

Analyst upgrades:

• Roth Capital upgraded MicroStrategy (NASDAQ: MSTR) to Buy from Hold and raised its target to $90 from $70, citing encouraging Q2 results, new product cycle catalysts, a lift from Europe, and cost reductions.
• William Blair upgraded Costco (NASDAQ: COST) to Outperform from Market Perform after meeting with management as it believes sales and earnings could beat expectations over the next year.
• Credit Suisse upgraded Novellus (NASDAQ: NVLS) to Outperform from Neutral and raised its target to $29 from $23. The firm cites higher Samsung capex forecast, high leverage, and low expectations.
• Home Properties (NYSE: HME) and Equity Residential (NYSE: EQR) were upgraded to Outperform from Market Perform at FBC Capital, while Douglas Emmett (NYSE: DEI) and Duke Realty (NYSE: DRE) were raised to Market Perform from Underperform.
• Agilent (NYSE: A) was upgraded to Overweight from Equal Weight at Barclays.
• Cytec Industries (NYSE: CYT) was upgraded to Buy from Hold at KeyBanc.

Analyst upgrades:

• Royal Bank of Scotland upgraded shares of Vodafone (NYSE: VOD) to Buy from Hold to reflect the company's dividend yield.
  
• JMP Securities expects HFF Inc. (NYSE: HF) to benefit from increased U.S. commercial real estate sales and mortgage volumes. Shares were upgraded to Outperform from Market Perform. The firm has a $5 target on shares.
  
• Oppenheimer upgraded Church & Dwight (NYSE: CHD) to Outperform from Perform as it believes Church & Dwight's value-oriented portfolio should continue to benefit from the consumer trade-down and that concerns over distribution are overblown. The firm set a $62 price on shares.
• Regeneron (NASDAQ: REGN) was upgraded to Buy from Neutral at Piper Jaffray.
  
• Burlington Northern (NYSE: BNI) was raised to Buy from Neutral at Goldman.
• AMB Property (NYSE: AMB) was lifted to Neutral from Underperform at Banc of America/Merrill.

AMB Property (NYSE: AMB), a global developer and owner of industrial real estate, closed at $13.25 Wednesday. Goldman Sachs says: "We remain cautious on REITS." AMB December option implied volatility of 107 is above its 8-week average of 66 according to Track Data, suggesting larger price movement.

Essex Property Trust (NYSE: ESS), a REIT with the majority of real estate consisting of apartment communities, closed at $74.33 Wednesday. ESS December option implied volatility of 81 is above its 26-week average of 51 according to Track Data, suggesting larger price movement.

AvalonBay (NYSE: AVB), an owner or indirect owner of 178 apartment communities containing 50,370 apartment homes, closed at $55.03 Wednesday. AVB December option implied volatility of 83 is above its 26-week average of 54 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

The earnings crunch begins in earnest this coming week, with companies from Johnson & Johnson (NYSE: JNJ) and PepsiCo Inc. (NYSE: PEP) to Southwest Airlines Co. (NYSE: LUV) and Harley-Davidson Inc. (NYSE: HOG) scheduled to report results for the quarter just ended. But with the ongoing turmoil in the markets, much attention is on the tech and financial sectors. This week will provide plenty to mull over on both counts.

Wall Street expectations for tech stocks are fairly optimistic. Analysts surveyed by Thomson Financial are looking for chip maker Altera Corp. (NASDAQ: ALTR) and software/service company iGate Corp. (NASDAQ: IGTE) to be the sector's biggest earnings gainers of the week. Altera is expected to report earnings of 30 cents per share (up 33.3% from a year ago) on revenue of $355.1 million. Altera had previously forecast flat sales for the quarter, and shares fell to a 52-week low last week. iGate is expected to report earnings of 14 cents per share (up 42.9%) on revenue of $55.6 million. India-based iGate recently spun off its Mastech consulting services. Shares are down 45.0% in the past three months, and also reached a new 52-week low last week.

San Jose-based Novellus Systems Inc. (NASDAQ: NVLS), on the other hand, is expected to report that net income tumbled 90.4% from a year ago to 4 cents per share, on revenue of $245.6 million. Novellus fell to a 52-week low early last week, and shares are down 44.5% year to date.

MOST NOTEWORTHY: Nova BioSource, Aventine Renewable and the REIT Sector were today's noteworthy initiations:

• ThinkPanmure believes Nova BioSource's (AMEX:NBF) biodiesal production process is economically superior to traditional processes but higher feedstock costs will make scaling difficult. Shares were initiated with an Accumulate rating.
  
• ThinkPanmure also initiated Aventine Renewable (NYSE:AVR) with an Accumulate rating and $8 target. The firm does not expect share upside until margin visibility improves, which will not occur until next year's corn crop materializes in early 2009.
  
• Lehman initiated the REIT sector with a Neutral rating; the firm started AMB Property (NYSE:AMB) and Kimco Realty (NYSE:KIM) with Overweight ratings and CBL & Associates (CBL) with an Underweight rating.

OTHER INITIATIONS:

• JP Morgan initiated BLADEX (NYSE:BLX) and Banco Santander (NYSE:SAN) with Overweight ratings.
• KeyBanc assumed Capital Lease Funding (NYSE:LSE) with a Hold rating.